Concentra Group Holdings Parent, Inc. (CON) P/E Ratio History
Premium ValuationTrading at 23.2x vs 5Y avg 17.4x · 86th percentile · Premium to historical baseline · Data 2024–2026
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Concentra Group Holdings Parent, Inc. (CON) trades at a price-to-earnings ratio of 23.2x, with a stock price of $30.15 and trailing twelve-month earnings per share of $1.39.
The current P/E is 33% above its 5-year average of 17.4x. Over the past five years, CON's P/E has ranged from a low of 15.0x to a high of 23.3x, placing the current valuation at the 86th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, CON is roughly in line with its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, CON trades roughly in line with the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CON DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CON Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CON P/E vs Peers
Digital Health and Care Delivery peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $634M | 13.7Lowest | - | -15% | |
| $14B | 24.8 | 1.06Best | +25%Best | |
| $2B | 14.0 | - | -29% | |
| $1B | 48.4 | - | -23% | |
| $27B | 69.3 | - | +12% | |
| $3B | 17.2 | - | +3% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CON Historical P/E Data (2024–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $21.45 | $1.38 | 15.5x | -11% |
| FY2025 Q4 | Dec 31 2025 | $19.68 | $1.30 | 15.1x | -13% |
| FY2025 Q3 | - | $20.93 | $1.19 | 17.6x | +1% |
| FY2025 Q2 | Jun 30 2025 | $20.57 | $1.17 | 17.6x | +1% |
| FY2025 Q1 | Mar 31 2025 | $21.70 | $1.24 | 17.5x | +1% |
| FY2024 Q4 | - | $19.78 | $1.32 | 15.0x | -14% |
| FY2024 Q3 | Sep 30 2024 | $22.36 | $0.96 | 23.3x | +34% |
Average P/E for displayed period: 17.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CON — Frequently Asked Questions
Quick answers to the most common questions about buying CON stock.
What is CON's P/E ratio?
Concentra Group Holdings Parent, Inc. (CON) trailing twelve-month P/E ratio is 23.2x, based on TTM diluted EPS of $1.39. The 5-year average P/E is 17.4x and the historical range spans 15.0x to 23.3x.
Is CON stock overvalued or undervalued?
CON trades at 23.2x P/E, above its 5-year average of 17.4x. The 86th percentile ranking within the 15.0x–23.3x historical range indicates a premium to historical valuation.
Is CON stock expensive?
Yes, CON is expensive relative to its own history. The current P/E of 23.2x is above the 5-year average of 17.4x and also above the Healthcare sector median of 23.0x. The stock sits at the 86th percentile of its 5-year valuation range.
What is CON's historical P/E range?
Over the past 5 years, CON's P/E ratio has ranged from 15.0x to 23.3x, with a median of 17.5x and an average of 17.4x. The current P/E of 23.2x places the stock at the 86th percentile of this range. Full historical data spans 2024–2026.
How does CON's P/E compare to the S&P 500?
CON trades at 23.2x P/E versus the S&P 500 median of 25.3x. The 8% discount to the market suggests lower growth expectations or perceived higher risk.
How does CON's valuation compare to Healthcare peers?
Concentra Group Holdings Parent, Inc. P/E of 23.2x compares to the Healthcare sector median of 23.0x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CON's PEG ratio?
CON PEG ratio is N/A, based on a P/E of 23.2x and EPS growth of 0.0%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CON's earnings yield?
CON earnings yield is 4.31%, the inverse of its 23.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.